Ascendis Pharma A (ASND) Research & Development (2016 - 2025)
Historic Research & Development for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to -$78.2 million.
- Ascendis Pharma A's Research & Development rose 319.71% to -$78.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.1 million, marking a year-over-year decrease of 248.84%. This contributed to the annual value of $332.3 million for FY2024, which is 2530.5% down from last year.
- Per Ascendis Pharma A's latest filing, its Research & Development stood at -$78.2 million for Q3 2025, which was up 319.71% from $81.5 million recorded in Q2 2025.
- Ascendis Pharma A's 5-year Research & Development high stood at $121.3 million for Q3 2023, and its period low was -$80.8 million during Q3 2024.
- Moreover, its 5-year median value for Research & Development was $93.4 million (2022), whereas its average is $77.0 million.
- Per our database at Business Quant, Ascendis Pharma A's Research & Development soared by 26746.48% in 2021 and then crashed by 16657.86% in 2024.
- Quarter analysis of 5 years shows Ascendis Pharma A's Research & Development stood at $75.1 million in 2021, then skyrocketed by 47.55% to $110.8 million in 2022, then dropped by 11.76% to $97.8 million in 2023, then dropped by 13.35% to $84.7 million in 2024, then tumbled by 192.27% to -$78.2 million in 2025.
- Its last three reported values are -$78.2 million in Q3 2025, $81.5 million for Q2 2025, and $91.1 million during Q1 2025.